Patents by Inventor Shamal A. Mehta

Shamal A. Mehta has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Substituted 3-carboxamido isoxazoles as kinase modulators
    Patent number: 7767670
    Abstract: The invention provides methods and compositions for treating conditions mediated by various kinases wherein substituted 3-carboxamido isoxazoles compounds are employed. The invention also provides methods of using the compounds and/or compositions in the treatment of a variety of diseases and unwanted conditions in subjects.
    Type: Grant
    Filed: November 15, 2004
    Date of Patent: August 3, 2010
    Assignee: Ambit Biosciences Corporation
    Inventors: Shamal A. Mehta, Robert M. Grotzfeld, Zdravko V. Milanov, Andiliy G. Lai, Hitesh K. Patel, David J. Lockhart
  • UREA DERIVATIVES AS ABL MODULATORS
    Publication number: 20100173917
    Abstract: The invention provides methods and compositions for treating conditions mediated by Bcr-Abl. The invention also provides methods of using the compounds and/or compositions in the treatment of a variety of diseases and unwanted conditions in subjects.
    Type: Application
    Filed: February 26, 2010
    Publication date: July 8, 2010
    Inventors: Robert M. Grotzfeld, Hitesh K. Patel, Shamal A. Mehta, Zdravkö V. Milanov, Andiliy G. Lai
  • Isoxazolyl urea derivatives as kinase modulators
    Patent number: 7750160
    Abstract: The invention provides methods and compositions for treating conditions mediated by various kinases wherein derivatives of urea compounds are employed. The invention also provides methods of using the compounds and/or compositions in the treatment of a variety of diseases and unwanted conditions in subjects.
    Type: Grant
    Filed: November 15, 2004
    Date of Patent: July 6, 2010
    Assignee: Ambit Biosciences Corporation
    Inventors: Zdravko V. Milanov, Hitesh K. Patel, Robert M. Grotzfeld, Shamal A. Mehta, Andiliy G. Lai, David J. Lockhart
  • CONJUGATED SMALL MOLECULES
    Publication number: 20100048890
    Abstract: Provided herein are linker compounds and conjugates that include the linker compounds. In one embodiment, the linker compounds comprise 2 or 3 residues of 6-aminohexanoic acid and optionally 7-10 residues of polyethyleneglycol (PEG). The linker compounds are useful in forming conjugates with one or more components useful in biopharmaceutical or bioanalytical applications. In particular, the biopharmaceutically useful compounds are kinase inhibitors. The conjugates described herein have utility in a variety of diagnostic, separation, and therapeutic applications.
    Type: Application
    Filed: June 30, 2009
    Publication date: February 25, 2010
    Inventors: Robert M. Grotzfeld, Zdravko V. Milanov, Hitesh K. Patel, Andiliy G. Lai, Shamal A. Mehta, David J. Lockhart